-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
ILMN Stock – The New Illumina Human Genome Machine Is a Game Changer
Illumina says it has developed a DNA sequencing machine that can scan a genome for under $1,000, sending ILMN stock higher.
Trade of the Day: UnitedHealth Group (UNH)
Trends aren’t random in the stock market today and, therefore, technicians have compelling historical evidence of the value of their methods.
5 Biotech Stocks With Big Catalysts on the Horizon
Announcements from, or about, these biotech stocks could greatly inflate their values ... or completely deflate them.
ICPT: Time to Catch a Rising Star With Intercept Stock?
It's never too late to invest in a long-term winner, and pharmaceutical player Intercept is on a long-term run. Here's why you should join the race...
ACT: Actavis’s Growth Potential Anything But Generic
Pharmaceutical company Actavis is at the forefront on the production of biologic drugs, and stands to profit from them well into the future. It's a buy!
XBI – Be Careful With This Biotech ETF After Its Violent Breakout
After last week's breakout and rally, the SPDR S&P Biotech ETF (XBI) is well overbought. Traders must closely watch Intercept Pharmaceuticals (ICPT).
GILD: Get on While Biotech Remains Hot
The bulls seemingly are unwilling to cast off biotech. And among the sector's biggest stocks, Gilead Sciences (GILD) has the most appealing setup.
Trade of the Day: Gilead Sciences (GILD)
Use the low-volume atmosphere around the New Year’s holiday to establish positions at a discount.
Trade of the Day: HCA Corp. (HCA)
I see one blue-chip chart after another showing upward momentum continuing for the next two weeks ahead.
The One Stock You Must Sell Now Is Eli Lilly
Eli Lilly's in a position where patents are coming off faster than new products are coming on board, a bad sign for a stock you should sell right now....
Trade of the Day: PerkinElmer (PKI)
With our indicators returning to bullish mode, you should return to favoring bullish options trades over bearish ones.
5 Pharma Stocks to Buy for Big Dividends
Drugmakers aren't known for big dividends, but the pharmaceutical industry can actually offer something for income investors.
Alzheimer’s Stocks Are a Stealth Opportunity
Alzheimer's stocks could mean huge rewards for investors, but as always, you have to pick the right ones. Here are three with solid prospects.
Are You Prepared for a Stronger Dollar?
What happens to the stock market if the U.S. dollar rallies? This question isn’t getting much press, but dollar strength could surprise the markets in 2014.
Don’t Buy Orexigen on Diet Pill Hopes
Orexigen Therapeutics joins VIVUS and Arena Pharmaceuticals in an industry that's brought nothing but disappointment to investors: weight-loss drugs.
Ask Louis: What Is Your Favorite Sector Right Now?
I'm always asked what sector I'm bullish on right now, and today I'd have to say the answer is healthcare, biotech, and pharmaceuticals. Here's why.
Why Shares of SRPT Stock Sank 65%
Sarepta Therapeutics stock plunged in Tuesday trading on a widening quarterly loss and a negative report on a key drug from the FDA.
What Valuations Are Trying to Tell Investors Right Now
Based on current valuations, the defensive consumer staples, utilities and healthcare sectors remain expensive. Where can you find better opportunities?
Trade of the Day: Boston Scientific (BSX)
Wall Street has been selling Boston Scientific (BSX) since it reported earnings, yet put options are still reasonably priced.
